A high triglyceride (TG)–low high-density lipoprotein cholesterol (HDL-C) level (TG 1.60 mmol/L [ 142 mg/dL] and HDL-C 1.18 mmol/L [ 46 mg/dL]) is associated with a high risk of ischemic heart disease (IHD), whereas a low TG–high HDL-C level (TG 1.09 [ 97 mg/dL] and HDL-C 1.48 mmol/L [ 57 mg/dL]) is associated with a low risk.
Conventional risk factors tend to coexist with high TG–low HDL-C levels.
In an observational cohort study of 2906 men aged 53 to 74 years free of IHD at baseline, we tested the hypothesis that subjects with conventional risk factors would still have a low risk of IHD if they had low TG–high HDL-C levels.
During 8 years, 229 subjects developed IHD. Stratified by conventional risk factors, such as:
- low-density lipoprotein cholesterol level ( 4.40 mmol/L or >4.40 mmol/L [ 170 mg/dL or >170 mg/dL] [median value]),
- hypertensive status (blood pressure >150/100 mm Hg or taking medication),
- level of physical activity (>4 h/wk or 4 h/wk), and
- smoking status (nonsmokers vs smokers) -
The incidence in men with high TG–low HDL-C levels was:
- 9.8% to 12.2% in the low-risk and
- 12.2% to 16.4% in the high-risk strata.
The corresponding values in men with low TG–high HDL-C concentrations were:
- 4.0% to 5.1% and
- 3.7% to 5.3%, respectively.
Based on an estimate of attributable risk, 35% of IHD might have been prevented if all subjects had had low TG–high HDL-C levels.
Conclusion:
Men with conventional risk factors for IHD have a low risk of IHD if they have low TG–high HDL-C levels.
Source: Jørgen Jeppesen, MD; Hans Ole Hein, MD; Poul Suadicani, DD; Finn Gyntelberg, MD, Low Triglycerides–High High-Density Lipoprotein Cholesterol and Risk of Ischemic Heart Disease (Arch Intern Med. 2001;161:361-366).
From The Copenhagen Male Study, Epidemiological Research Unit, Copenhagen University Hospital, Bispebjerg (Drs Jeppesen, Hein, Suadicani, and Gyntelberg), and The Glostrup Population Studies, Department of Internal Medicine C, Glostrup University Hospital, Glostrup (Dr Hein), Denmark.
Corresponding author and reprints: Jørgen Jeppesen, MD, The Copenhagen Male Study, Epidemiological Research Unit, Copenhagen University Hospital, Bispebjerg, Bispebjerg Bakke 23, DK-2400 Copenhagen NV, Denmark.